Just as taking Tenofovir as HIV treatment is a long term therapy (forever, or until a better drug is on the market), PrEP is a long term, everyday therapy too. Anyone who is considering PrEP ought be looking at the whole picture, and then making the choice which s b best for them.
But is drug development more controlled by what will impact their profit margin? Of course, drug companies like any businesses have a right to make profits, but how many billions is enough? And why aren’t HIV/AIDS activists speaking out against such profit hogging?
The downside is that we are placing a lot of power in the hands of a single drug company, and I think we can be sure that decisions being made serve their financial bottom line far more than they serve the common good.
PrEP is a preventive tool in the fight against HIV infection. This may be increasing the amount of unprotected sex that men have, and causing a rise in STDs.
We know so much about how HIV is spread, we ought to be able to stop the spread of HIV. Yet every year more gay and bi men become infected. Why is that? There is a perpetuating cycle of HIV infection.
Last week, results of a 32 month long real world study were released which show that PrEP is effective in stopping the spread of HIV.
People who are positive are not the cause of spreading HIV. People who don’t know their status are the cause.
Ending the epidemic of HIV is actually very simple: frequent testing; following safer sex practices; and for those who are positive, adhering to treatments so that your viral load remains undetectable.
I often post my weekly HIV/AIDS post on Monday or Tuesday, but I’m going to jump in and post it today, as the topic regards Sunday July 12. A link to the HuffPost story I’m quoting is below. The article is powerful and inspiring, and a must read in my opinion. The black church has always been a place of power for the African-American community. It was where black leaders secretly preached the gospel of[Read More…]
A recent study in monkeys is being touted as great news and a real break through when it comes to finding a vaccine to protect people from being infected with HIV. The quote here is from a report on latinoshealth.com: … the research team has incorporated the vaccine in monkeys by means of adenovirus 26, a common cold virus, to help develop antibodies. A second vaccine containing a surface protein of HIV is then added.[Read More…]